Akzo Nobel Management
Management criteria checks 3/4
Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 2.5 years. total yearly compensation is €5.37M, comprised of 24% salary and 76% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth €1.90M. The average tenure of the management team and the board of directors is 3.1 years and 1.7 years respectively.
Key information
Greg Poux-Guillaume
Chief executive officer
€5.4m
Total compensation
CEO salary percentage | 24.03% |
CEO tenure | 2.5yrs |
CEO ownership | 0.02% |
Management average tenure | 3.1yrs |
Board average tenure | 1.7yrs |
Recent management updates
Recent updates
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively
May 22Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54
Apr 18Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?
Mar 26Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price
Mar 14Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54
Feb 12Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 50% Undervaluation?
Jan 27There's Been No Shortage Of Growth Recently For Akzo Nobel's (AMS:AKZA) Returns On Capital
Jan 13Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching
Nov 25Steady Streamlining And Strategic Expansion Ignite A Brighter Future
Efficiency programs and workforce reductions are set to bolster net margins through significant cost savings.Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Oct 14Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price
Oct 01Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher
Sep 17What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?
Aug 21Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt
Jul 03Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jun 20Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price
Jun 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2025 | n/a | n/a | €467m |
Dec 31 2024 | €5m | €1m | €542m |
Sep 30 2024 | n/a | n/a | €565m |
Jun 30 2024 | n/a | n/a | €592m |
Mar 31 2024 | n/a | n/a | €534m |
Dec 31 2023 | €5m | €1m | €447m |
Sep 30 2023 | n/a | n/a | €411m |
Jun 30 2023 | n/a | n/a | €309m |
Mar 31 2023 | n/a | n/a | €303m |
Dec 31 2022 | €2m | €204k | €362m |
Compensation vs Market: Greg's total compensation ($USD6.10M) is about average for companies of similar size in the Dutch market ($USD5.62M).
Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.
CEO
Greg Poux-Guillaume (54 yo)
Mr. Gregoire Poux-Guillaume, also known as Greg, was Chairman of the Board at medmix AG since September 20, 2021 and continues to served as its Director since 2024. He had been the Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman of the Management Board | 2.5yrs | €5.37m | 0.019% € 1.9m | |
CFO & Member of Management Board | 7.3yrs | €2.94m | 0.022% € 2.2m | |
Head Of Investor Relations | no data | no data | no data | |
General Counsel | 1.3yrs | no data | no data | |
Chief Human Resources Officer | 1.8yrs | no data | no data | |
CEO of Specialty Chemicals | 6.6yrs | no data | no data | |
Chief Integrated Supply Chain Officer | 3.7yrs | no data | no data | |
Chief Development Officer | less than a year | no data | no data | |
Group Treasurer | 9.3yrs | no data | no data |
Experienced Management: AKZA's management team is considered experienced (3.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Supervisory Board Chairman | 2.1yrs | €184.00k | 0.0014% € 137.7k | |
Independent Deputy Chairman of the Supervisory Board | 11.1yrs | €142.00k | no data | |
Independent Member of Supervisory Board | 3.1yrs | €112.00k | no data | |
Member of the Supervisory Board | less than a year | no data | no data | |
Independent Member of Supervisory Board | 1.1yrs | €69.49k | no data | |
Independent Member of Supervisory Board | 1.1yrs | €78.58k | no data | |
Independent Member of Supervisory Board | 1.3yrs | €76.08k | no data | |
Independent Member of Supervisory Board | 3.1yrs | €120.50k | no data |
Experienced Board: AKZA's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/25 07:26 |
End of Day Share Price | 2025/05/23 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Akzo Nobel N.V. is covered by 55 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mutlu Gundogan | ABN AMRO Bank N.V. |
Martin Schnee | AlphaValue |
Colin Isaac | Atlantic Equities LLP |